S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-1.04%) $82.98
Gas
(-1.16%) $1.619
Gold
(-0.46%) $2 336.30
Silver
(-0.53%) $27.39
Platinum
(0.35%) $925.30
USD/EUR
(-0.11%) $0.934
USD/NOK
(-0.07%) $11.02
USD/GBP
(-0.19%) $0.799
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai Neuland Laboratories [NEULANDLAB.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta26 bal. 2024 @ 12:59

-1.67% INR 6 973.40

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson...

Stats
Šios dienos apimtis 30 726.00
Vidutinė apimtis 46 567.00
Rinkos kapitalizacija 89.47B
EPS INR0 ( 2024-02-08 )
Kita pelno data ( INR0 ) 2024-05-08
Last Dividend INR10.00 ( 2023-07-11 )
Next Dividend INR0 ( N/A )
P/E 28.25
ATR14 INR6.08 (0.09%)

Tūris Koreliacija

Ilgas: -0.13 (neutral)
Trumpas: 0.86 (strong)
Signal:(46.983) Same movement expected

Neuland Laboratories Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Neuland Laboratories Koreliacija - Valiuta/Žaliavos

The country flag 0.38
( neutral )
The country flag 0.33
( neutral )
The country flag 0.69
( moderate )
The country flag 0.53
( weak )
The country flag -0.19
( neutral )
The country flag -0.59
( weak negative )

Neuland Laboratories Finansinės ataskaitos

Annual 2022
Pajamos: INR11.91B
Bruto pelnas: INR5.77B (48.47 %)
EPS: INR127.45
FY 2022
Pajamos: INR11.91B
Bruto pelnas: INR5.77B (48.47 %)
EPS: INR127.45
FY 2022
Pajamos: INR9.25B
Bruto pelnas: INR3.72B (40.18 %)
EPS: INR49.74
FY 2021
Pajamos: INR9.24B
Bruto pelnas: INR3.66B (39.55 %)
EPS: INR62.85

Financial Reports:

No articles found.

Neuland Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR5.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR10.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Neuland Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.32 - low (10.63%) | Divividend Growth Potential Score: 3.74 - Decrease likely (25.27%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.90 2009-07-13
Last Dividend INR10.00 2023-07-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out INR32.18 --
Avg. Dividend % Per Year 0.33% --
Score 1.8 --
Div. Sustainability Score 3.32
Div.Growth Potential Score 3.74
Div. Directional Score 3.53 --
Next Divdend (Est)
(2025-01-24)
INR12.33 Estimate 2.94 %
Dividend Stability
0.24 Very Poor
Dividend Score
1.80
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR1.200 0.25%
2020 INR4.00 0.96%
2021 INR3.00 0.28%
2022 INR5.00 0.32%
2023 INR10.00 0.60%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SBIN.NS Dividend Junior 2023-05-31 Sporadic 29 0.99%
MAHSEAMLES.NS Dividend Junior 2023-08-14 Annually 21 0.80%
GODFRYPHLP.NS Dividend Junior 2023-08-11 Annually 24 1.52%
AURIONPRO.NS Dividend Junior 2023-09-22 Sporadic 19 0.36%
TOUCHWOOD.NS Dividend Junior 2023-09-22 Annually 6 0.15%
PGIL.NS Dividend Junior 2023-09-01 Annually 17 1.08%
JINDALSAW.NS Dividend Junior 2023-06-13 Annually 22 1.62%
DEEPAKNTR.NS Dividend Junior 2023-07-27 Annually 14 0.25%
SKMEGGPROD.NS Dividend Junior 2023-08-30 Sporadic 21 0.95%
MGEL.NS Dividend Junior 2023-08-08 Annually 5 0.59%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2011.5005.998.98[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.2981.5007.8010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM29.441.0000.2090.209[3 - 30]
operatingCashFlowPerShareTTM88.402.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM88.402.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.5181.0004.714.71[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.32

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM28.221.0007.250[1 - 100]
returnOnEquityTTM0.2982.508.5810.00[0.1 - 1.5]
freeCashFlowPerShareTTM88.402.0010.0010.00[0 - 30]
dividendYielPercentageTTM0.1431.5006.410[0 - 0.4]
operatingCashFlowPerShareTTM88.402.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.3801.500-5.870[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07181.000-0.7060[0.1 - 0.5]
Total Score3.74

Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.